WallStreetZenWallStreetZen

NASDAQ: CLVS
CLOVIS ONCOLOGY INC Stock

Buy CLVS
$1.70-0.04 (-2.3%)
Updated Jun 24, 2022
CLVS Price
$1.70
Fair Value Price
$2.71
Market Cap
$244.59M
52 Week Low
$0.58
52 Week High
$6.64
P/E
-0.81x
P/B
-0.81x
P/S
1.93x
PEG
N/A
Dividend Yield
N/A
Revenue
$144.95M
Earnings
-$258.42M
Gross Margin
73.4%
Operating Margin
-154.29%
Profit Margin
-178.3%
Debt to Equity
-2.49
Operating Cash Flow
-$193M
Beta
1.33
Next Earnings
Aug 2, 2022
Ex-Dividend
N/A
Next Dividend
N/A

CLVS Overview

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CLVS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CLVS ($1.70) is undervalued by 37.23% relative to our estimate of its Fair Value price of $2.71 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CLVS ($1.70) is significantly undervalued by 37.23% relative to our estimate of its Fair Value price of $2.71 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
CLVS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CLVS due diligence checks available for Premium users.

CLVS News

Valuation

CLVS fair value

Fair Value of CLVS stock based on Discounted Cash Flow (DCF)
Price
$1.70
Fair Value
$2.71
Undervalued by
37.23%
CLVS ($1.70) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CLVS ($1.70) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CLVS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CLVS price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.81x
Industry
-2.58x
Market
20.48x

CLVS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-0.81x
Industry
4.43x

CLVS's financial health

Profit margin

Revenue
$34.2M
Net Income
-$60.2M
Profit Margin
-175.7%
CLVS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CLVS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$451.5M
Liabilities
$754.8M
Debt to equity
-2.49
CLVS's short-term assets ($185.54M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CLVS's long-term liabilities ($633.00M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CLVS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CLVS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$58.5M
Investing
-$62.0k
Financing
$37.9M
CLVS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CLVS vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
CLVS$244.59M-2.30%-0.81x-0.81x
OTLK$246.28M+5.83%-3.41x6.85x
EYPT$246.84M-3.85%-3.45x1.48x
MOLN$239.21M-7.27%N/A0.90x
CBAY$238.79M+8.88%-2.10x2.22x

CLOVIS ONCOLOGY Stock FAQ

What is CLOVIS ONCOLOGY's quote symbol?

(NASDAQ: CLVS) CLOVIS ONCOLOGY trades on the NASDAQ under the ticker symbol CLVS. CLOVIS ONCOLOGY stock quotes can also be displayed as NASDAQ: CLVS.

What is the 52 week high and low for CLOVIS ONCOLOGY (NASDAQ: CLVS)?

(NASDAQ: CLVS) CLOVIS ONCOLOGY's 52-week high was $6.64, and its 52-week low was $0.58. It is currently -74.4% from its 52-week high and 192.6% from its 52-week low.

How much is CLOVIS ONCOLOGY stock worth today?

(NASDAQ: CLVS) CLOVIS ONCOLOGY currently has 143,879,140 outstanding shares. With CLOVIS ONCOLOGY stock trading at $1.70 per share, the total value of CLOVIS ONCOLOGY stock (market capitalization) is $244.59M.

CLOVIS ONCOLOGY stock was originally listed at a price of $12.56 in Nov 16, 2011. If you had invested in CLOVIS ONCOLOGY stock at $12.56, your return over the last 10 years would have been -86.46%, for an annualized return of -18.13% (not including any dividends or dividend reinvestments).

How much is CLOVIS ONCOLOGY's stock price per share?

(NASDAQ: CLVS) CLOVIS ONCOLOGY stock price per share is $1.70 today (as of Jun 24, 2022).

What is CLOVIS ONCOLOGY's Market Cap?

(NASDAQ: CLVS) CLOVIS ONCOLOGY's market cap is $244.59M, as of Jun 25, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

CLOVIS ONCOLOGY's market cap is calculated by multiplying CLVS's current stock price of $1.70 by CLVS's total outstanding shares of 143,879,140.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.